Marie® by Leo Cancer Care Makes History at Stanford Medicine — World First in Compact Upright Proton Therapy

Key Takeaways

• First upright proton therapy performed on a child at Stanford.
• Marie® shrinks size >90%, from 29k to 1.7k sq ft.
• Fixed‑beam design fits into existing radiotherapy vaults.
• Upright position boosts comfort and clinician‑patient interaction.
• Lower costs could unlock proton therapy for many hospitals.

Pulse Analysis

Proton therapy has long been hailed for its ability to spare healthy tissue, yet its adoption has been hampered by massive gantries and dedicated facilities that cost hundreds of millions of dollars. Traditional systems occupy over 29,000 sq ft and require custom‑built vaults, limiting availability to a small number of elite cancer centers. The recent milestone at Stanford Medicine demonstrates how rethinking geometry—rotating the patient instead of the beam—can dismantle these physical constraints, ushering in a new era of compact, cost‑effective proton solutions.

Leo Cancer Care’s Marie® platform combines a 360‑degree rotating chair with integrated upright CT imaging, delivering proton beams from a fixed source. This design not only reduces the footprint to roughly 1,700 sq ft but also places patients in a natural, standing‑or‑seated posture. For pediatric cases, the upright stance eases breathing, improves immobilization, and fosters eye‑to‑eye communication with clinicians, enhancing comfort and potentially reducing motion‑related uncertainties. The accompanying StatueQuest game further personalizes the experience, turning treatment sessions into interactive adventures.

The commercial implications are profound. By lowering the capital threshold and enabling retro‑fit installations within existing radiotherapy suites, hospitals that previously could not justify proton therapy may now consider it viable. This could expand the addressable market from a few dozen centers to hundreds worldwide, accelerating research, improving outcomes, and driving competition that may lower prices. As Leo Cancer Care partners with Mevion and other technology providers, the industry can expect a cascade of similar compact installations, reshaping radiation oncology’s landscape over the next decade.